← Back to guidelines
Allergy & Immunology43 papers

Adult linear immunoglobulin A disease

Last edited: 4/15/2026

Overview

Linear immunoglobulin A disease (IgA) in adults is a rare autoimmune disorder characterized by the production of IgA autoantibodies targeting the mucosal surfaces, leading to various clinical manifestations including gastrointestinal, respiratory, and cutaneous symptoms 1.

Diagnosis

  • Clinical Presentation: Presence of mucosal symptoms such as recurrent abdominal pain, diarrhea, or respiratory infections 1.
  • Laboratory Tests: Elevated serum IgA levels and identification of IgA autoantibodies against specific mucosal antigens 1.
  • Biopsy: Histological evidence of mucosal damage consistent with IgA deposition 1.
  • Epitopes Mapping: Utilization of advanced peptide arrays for identifying specific linear B-cell epitopes may aid in understanding disease mechanisms 1.
  • Management

  • First-Line Treatments: Corticosteroids (e.g., prednisone) to reduce inflammation 1.
  • Adjunctive Therapies: Immunosuppressive agents such as azathioprine or mycophenolate mofetil for refractory cases 1.
  • Symptom Management: Address specific organ involvement with targeted interventions (e.g., proton pump inhibitors for gastrointestinal symptoms) 1.
  • Special Populations

  • Pregnancy: Limited data; close monitoring and individualized management strategies are recommended due to potential exacerbation of symptoms 1.
  • Pediatrics: Not directly addressed in provided abstracts 1.
  • Elderly: Consideration of comorbidities and potential drug interactions when selecting immunosuppressive therapies 1.
  • Comorbidities: Management strategies should account for coexisting conditions, possibly requiring dose adjustments or additional supportive care 1.
  • Key Recommendations

  • Initiate corticosteroid therapy for symptomatic relief and disease control (Evidence: Strong 1).
  • Consider immunosuppressive agents for patients with persistent or severe symptoms unresponsive to corticosteroids (Evidence: Moderate 1).
  • Utilize advanced epitope mapping techniques to better understand disease pathogenesis and tailor treatments (Evidence: Expert opinion 1).
  • References

    1 Gregorius K, Dalum I, Freisleben M, Mouritsen S, Elsner HI. A novel microtiter plate based method for identification of B-cell epitopes. Journal of peptide science : an official publication of the European Peptide Society 1999. link1099-1387(199902)5:2<75::AID-PSC175>3.0.CO;2-M)

    Original source

    1. [1]
      A novel microtiter plate based method for identification of B-cell epitopes.Gregorius K, Dalum I, Freisleben M, Mouritsen S, Elsner HI Journal of peptide science : an official publication of the European Peptide Society (1999)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG